UK To Launch World’s First 7-Minute Cancer Treatment Jab

News Desk

Islamabad: The invasive cancer treatment is considered expensive, but it is also painful and time-consuming. However, for the first time, patients in England with multiple types of cancer will be treated with a jab in just 7 minutes.

Britain’s state-run national health service will be the first in the world to offer an injection that treats cancer to hundreds of patients in England which could cut treatment times by up to three quarters.

Following approval from the Medicines and Healthcare products Regulatory Agency (MHRA), National Health Service (NHS) England said that hundreds of eligible patients treated with the immunotherapy, atezolizumab, were set to have “under the skin” injection which will free up more time for cancer teams.

According to Reuters, facilities to treat patients within seven minutes will be available in all public hospitals in England, under which patients will be injected like a normal injection.

The report stated that the injection called ‘Tecentriq’ was earlier given by doctors through ‘intravenous injection’ (IV). That is, the injection was administered to the patients earlier in the form of an IV drip which required one to one and a half hours, but now the same injection can be administered to the patients within seven minutes.

The injection will be administered like any other common pain and fever injection; however, the drug in it will be injected into the human body within 7 minutes, while the normal injection is sometimes injected into the human body within a minute.

The drug, also known as Tecentriq, treats different types of cancer, including lung, breast, liver and bladder cancers. It is given to about 3,600 patients in England each year.

‘Tecentriq’ works as an immunotherapy, i.e., by strengthening the human body’s immune system to fight cancer-causing cells.

This injection has been administered as an IV drip for a long time in many countries to cancer patients undergoing chemotherapy, but now it can be administered as a regular injection.

Experts hope that more patients will be able to benefit from this method in less time and that the results will also be good.